Table 3.
Tumor organoid line (chemotolerant vs ctrl) | Hallmark | NES | NOM P value |
---|---|---|---|
PDTO1 | HALLMARK_ANGIOGENESIS | 1.583 | .032 |
HALLMARK_COAGULATION | 1.524 | .035 | |
HALLMARK_COMPLEMENT | 1.357 | .055 | |
HALLMARK_INTERFERON_ALPHA_RESPONSE | 1.406 | .056 | |
PDTO2 | HALLMARK_MYC_TARGETS_V1 | 2.178 | .000 |
HALLMARK_E2F_TARGETS | 1.924 | .000 | |
HALLMARK_MYC_TARGETS_V2 | 1.886 | .000 | |
HALLMARK_INTERFERON_ALPHA_RESPONSE | 1.447 | .028 | |
HALLMARK_G2M_CHECKPOINT | 1.238 | .059 | |
PDTO5 | HALLMARK_E2F_TARGETS | 2.103 | .000 |
HALLMARK_G2M_CHECKPOINT | 1.856 | .000 | |
HALLMARK_MYC_TARGETS_V1 | 1.697 | .000 | |
HALLMARK_MYC_TARGETS_V2 | 1.481 | .037 |
NOTE. The gene sets that are enriched after acquisition of chemotolerance are shown.
NES, normalized enrichment score; NOM P value, nominal P value.